Corvus Pharmaceuticals, Inc. (CRVS)

16.04 -1.80 (-10.06%) USD  |  NASDAQ  |  Mar 05, 16:00
16.07 +0.02 (+0.16%) After-Hours: 19:31
More

Corvus Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Jaguar Health, Inc. Upgrade
Krystal Biotech, Inc. Upgrade